Promising leukemia drug trial halted early – what it means for patients
Disease control
Terminated
This study tested a drug called calaspargase pegol in adults aged 22 to over 65 with a specific type of acute lymphoblastic leukemia (ALL) that lacks the Philadelphia chromosome. The goal was to find the right dose and check for side effects. The trial was stopped early, but the …
Phase: PHASE2, PHASE3 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control
Last updated Apr 29, 2026 02:07 UTC